Neko Health is bringing its $499 body-scanning technology to the US. The Swedish health-tech company is crossing the Atlantic after building its preventive screening business in Sweden and the UK.
The first US clinic will open Sept. 24 at 300 Lafayette Street in New York’s SoHo neighborhood, offering its one-hour Neko Health Scan for $499. More than 25,000 New Yorkers have joined the waitlist, according to the company.
Neko develops its hardware, software, and clinical protocols in-house, giving it control over both the technology and clinic experience. Other health-tech vendors are similarly trying to turn streams of biometric information into usable guidance; Samsung, for example, is testing an AI-powered Health Assistant that interprets wearable data to provide personalized wellness recommendations.
Neko was founded by Spotify cofounder Daniel Ek and CEO Hjalmar Nilsonne. The company enters the US after raising $700 million in a Series C round on July 15. Neko reports more than 350,000 people have joined its global waitlist or registered for a scan, with more than 100,000 scans completed in Sweden and the UK.
Neko sets $499 price for US launch
The SoHo location will span two floors and include seven scan rooms, making it one of Neko’s largest clinics. In its Aug. 18 launch announcement, the company also outlined plans for additional New York locations, followed by Miami, Washington, D.C., and San Francisco over the next year.
The $499 service is currently self-pay. Neko’s US medical terms state that it does not accept insurance, although customers can request documentation to seek possible reimbursement from an insurer. Reimbursement is not guaranteed.
That model makes the US rollout a commercial test of whether consumers will pay directly for sensor- and software-driven preventive screening outside traditional insurance-funded primary care.
Inside Neko’s one-hour health scan
The Neko Health Scan takes about 60 minutes and assesses the heart, skin, blood, circulation, body composition, and metabolic health. Its body-scanning system uses proprietary sensors without radiation, while separate bloodwork contributes laboratory data. A clinician reviews the results during the same visit.
Neko expanded the service in June with body-composition measurements and wearable integration. Customers with upcoming scans can connect Apple Health data, including steps, sleep, and heart-rate variability, allowing clinicians to consider activity and recovery information alongside scan results.
Apple Watch users can similarly view glucose data from compatible CGMs, illustrating how consumer health platforms can aggregate information generated by separate medical and wellness devices.
Neko’s scan is not a substitute for primary care, and its US terms say its clinics do not treat conditions identified through the service. That boundary is increasingly relevant as consumers turn to AI and digital tools for health information, while licensed clinicians remain responsible for diagnosis and treatment. Neko can recommend further investigation, but patients remain responsible for arranging follow-up care.
The Sept. 24 opening will test whether Neko’s vertically integrated health-tech model can turn strong European demand into US customers willing to pay $499 out of pocket. With four US markets already in its expansion plan, the SoHo clinic is the first step in a broader American rollout.
Read more: Consumer hardware is moving further into regulated healthcare as well, with Samsung recently securing FDA clearance for Galaxy Buds hearing-aid features, expanding the range of everyday devices taking on health-related functions.